论文部分内容阅读
本刊讯2014年12月26日,国家药品不良反应监测预警平台显示,安徽联谊药业股份有限公司生产的胞磷胆碱钠注射液(批号为131229)在广西壮族自治区发生聚集性不良事件,一些患者用药后出现寒战、发热症状。广西壮族自治区食品药品监督管理局立即组织对药品进行抽验,发现该批次药品“可见异物”“性状”项不符合规定。经查,2014年下半年在河南省也有个别患者使用该企业
On December 26, 2014, the National Adverse Drug Reaction Monitoring and Early Warning Platform revealed that citicoline sodium injection (batch No. 131229) produced by Anhui Lianyi Pharmaceutical Co., Ltd. had amassing adverse events in Guangxi Zhuang Autonomous Region. Some patients experienced chills and fever after medication. The Guangxi Zhuang Autonomous Region Food and Drug Administration immediately organized a random inspection of the drug and found that the batch of drugs “visible foreign matter ” “property ” did not meet the requirements. The investigation has also used the company in individual patients in Henan Province in the second half of 2014